STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal spray that may cause “adverse” effects. The NasoGel was recalled by the manufacturer, NeilMed Pharmaceuticals Inc., the FDA said.

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause “adverse” medical effects. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, issued a worldwide recall of the product due to potential “microbial failure.”

The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.